E

eclipse-orthopaedics

browser_icon
Company Domain www.eclipseortho.com link_icon
lightning_bolt Market Research

Eclipse Orthopaedics Market Research Report



Company Overview


  • Name: Eclipse Orthopaedics

  • Mission: Innovate orthopaedic devices to simplify surgical procedures and improve the quality of care, with goals focusing on shorter surgeries, simplified procedures, and safer outcomes.

  • Founded: By industry veteran David Rich.

  • Headquarters: 827 S Union St #230, Warsaw, IN 46580

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: Focused on improving internal fixation procedures for orthopaedic trauma, specifically targeting one of the biggest challenges—locating and drilling pilot holes for intramedullary nails.


Key People


  • Founder: David Rich


Products


Radiographic Targeting Attachment (RTA)


  • Description: A device under development designed to assist surgeons in performing distal locking procedures in orthopaedic surgeries. It aims to put both targeting and drilling capabilities directly into the surgeon's hands.

  • Key Features:

  • Eliminates the step of aligning the C-arm fluoroscopy to avoid the dependence on radiology technicians.

  • Reduces operative time and minimizes radiation exposure.

  • Is compatible with any nail system and drill, useful for hip and mid-shaft femur and tibia fractures.

  • Does not alter established surgical procedures, making it easy to learn and adopt.

  • Has been successfully tested for feasibility in cadaver studies.


Recent Developments


  • Research Support: The RTA is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award number R43AR074332.

  • Feasibility Demonstration: Successful cadaver study demonstrating the potential of the RTA device with five orthopaedic surgeons showing promising results.

  • Next Steps:

  • Focus on conducting a larger scale study to refine the RTA technology.

  • Preparation for regulatory approval through the validation of design, safety, and efficacy.

  • The RTA is still under development, not approved for human use, and not yet available for sale.


Additional Notes


  • Investment and Support: Eclipse Orthopaedics receives investment from Elevate Ventures and support at both regional and national levels.

  • Professional Team and Advisory Board:

  • A business leadership team knowledgeable about the orthopaedics industry and its regulatory environment.

  • A creative and proven engineering team with extensive orthopaedic experience.

  • An engaged medical advisory board providing expert counsel and insight.


Contact Information


  • Email: david@eclipseortho.com

  • Phone: (574) 306-4056


Financial and Policy Links


  • Financial Conflict of Interest Policy: Transparency in financial policies is upheld.


Disclaimer: The content is supported by research funded by the NIH and does not necessarily represent the official views of the NIH.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI